Cutler Group’s Heron Therapeutics HRTX Stock Holding History

Cutler Group’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	$7K	Sell	2,800 -100	-3%	-$250	﹤0.01%	680
2023 Q4	$4K	Hold	2,900	–	–	﹤0.01%	1115
2023 Q3	$2K	Hold	2,900	–	–	﹤0.01%	1254
2023 Q2	$3K	Hold	2,900	–	–	﹤0.01%	1176
2023 Q1	$4K	Hold	2,900	–	–	﹤0.01%	1159
2022 Q4	$7K	Hold	2,900	–	–	﹤0.01%	1358
2022 Q3	$12K	Sell	2,900 -436	-13%	-$1.8K	﹤0.01%	1326
2022 Q2	$9K	Sell	3,336 -1,600	-32%	-$4.32K	﹤0.01%	1402
2022 Q1	$28K	Buy	4,936 +2,036	+70%	+$11.5K	﹤0.01%	1245
2021 Q4	$26K	Hold	2,900	–	–	﹤0.01%	1401
2021 Q3	$31K	Hold	2,900	–	–	﹤0.01%	1384
2021 Q2	$45K	Buy	2,900 +1,100	+61%	+$17.1K	﹤0.01%	1266
2021 Q1	$29K	Buy	1,800 +1,700	+1,700%	+$27.4K	﹤0.01%	1344
2020 Q4	$2K	Sell	100 -7,149	-99%	-$143K	﹤0.01%	1651
2020 Q3	$107K	Buy	7,249 +2,749	+61%	+$40.6K	0.01%	652
2020 Q2	$66K	Sell	4,500 -2,900	-39%	-$42.5K	﹤0.01%	767
2020 Q1	$86K	Buy	+7,400	New	+$86K	﹤0.01%	631
2019 Q4	–	Sell	-4,500	Closed	-$83K	–	1767
2019 Q3	$83K	Buy	4,500 +1,600	+55%	+$29.5K	0.01%	656
2019 Q2	$53K	Buy	2,900 +2,300	+383%	+$42K	﹤0.01%	895
2019 Q1	$14K	Sell	600 -100	-14%	-$2.33K	﹤0.01%	1124
2018 Q4	$18K	Sell	700 -300	-30%	-$7.71K	﹤0.01%	1121
2018 Q3	$31K	Buy	1,000 +700	+233%	+$21.7K	﹤0.01%	1059
2018 Q2	$11K	Sell	300 -11,043	-97%	-$405K	﹤0.01%	1271
2018 Q1	$313K	Buy	+11,343	New	+$313K	0.03%	407
2017 Q4	–	Sell	-3,816	Closed	-$61K	–	2415
2017 Q3	$61K	Sell	3,816 -14,334	-79%	-$229K	﹤0.01%	1187
2017 Q2	$251K	Buy	18,150 +13,759	+313%	+$190K	0.01%	767
2017 Q1	$65K	Sell	4,391 -52,091	-92%	-$771K	﹤0.01%	1342
2016 Q4	$739K	Buy	56,482 +32,623	+137%	+$427K	0.03%	362
2016 Q3	$411K	Buy	23,859 +13,614	+133%	+$235K	0.02%	452
2016 Q2	$184K	Sell	10,245 -6,797	-40%	-$122K	0.01%	717
2016 Q1	$323K	Buy	17,042 +9,975	+141%	+$189K	0.02%	437
2015 Q4	$188K	Buy	+7,067	New	+$188K	0.01%	737